Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews.
暂无分享,去创建一个
K. Hamunen | D. Aldington | S. Derry | M. Haanpaa | P. Cole | R. A. Moore | P. J. Wiffen | Michael P T Lunn | Andrew S.C Rice | Katri Hamunen | Eija A Kalso | Eija A Kalso | Andrew S.C. Rice
[1] S. Straube,et al. The Costs and Consequences of Adequately Managed Chronic Non‐Cancer Pain and Chronic Neuropathic Pain , 2014, Pain practice : the official journal of World Institute of Pain.
[2] A. Oaklander,et al. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia , 2013, PAIN®.
[3] N. Puri,et al. WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia. , 2013, The Cochrane database of systematic reviews.
[4] P. Wiffen,et al. Topiramate for neuropathic pain and fibromyalgia in adults. , 2013, The Cochrane database of systematic reviews.
[5] R. Palmer,et al. Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial , 2013, Arthritis Research & Therapy.
[6] P. Wiffen,et al. Challenges in design and interpretation of chronic pain trials. , 2013, British journal of anaesthesia.
[7] C. Cooper,et al. Neuropathic features of joint pain: a community-based study. , 2013, Arthritis and rheumatism.
[8] D. Aldington,et al. Amitriptyline for neuropathic pain and fibromyalgia in adults. , 2013, The Cochrane database of systematic reviews.
[9] T. Tölle,et al. Duloxetine use in chronic painful conditions – individual patient data responder analysis , 2013, European journal of pain.
[10] Daniel Zeller,et al. Small fibre pathology in patients with fibromyalgia syndrome. , 2013, Brain : a journal of neurology.
[11] E. Kalso,et al. Expect analgesic failure; pursue analgesic success , 2013, BMJ.
[12] S. Straube,et al. Pain measures and cut‐offs – ‘no worse than mild pain’ as a simple, universal outcome , 2013, Anaesthesia.
[13] Z. Gabriel,et al. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population , 2013, BMC Family Practice.
[14] R. Moore,et al. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. , 2012, The Cochrane database of systematic reviews.
[15] P. Wiffen,et al. COMBINATION PHARMACOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN IN ADULTS , 2012, The Cochrane database of systematic reviews.
[16] R. Moore,et al. Phenytoin for neuropathic pain and fibromyalgia in adults. , 2012, The Cochrane database of systematic reviews.
[17] P. Wiffen. CLONAZEPAM FOR NEUROPATHIC PAIN AND FIBROMYALGIA IN ADULTS , 2012, The Cochrane database of systematic reviews.
[18] R. Dworkin,et al. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? , 2012, PAIN®.
[19] A. Bhigjee,et al. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[20] R. Moore,et al. SUMATRIPTAN (ORAL ROUTE OF ADMINISTRATION) FOR ACUTE MIGRAINE ATTACKS IN ADULTS , 2012, The Cochrane database of systematic reviews.
[21] C. Eccleston,et al. Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses , 2012, PAIN.
[22] P. Wiffen,et al. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. , 2011, The Cochrane database of systematic reviews.
[23] E. Kalso,et al. A new definition of neuropathic pain , 2011, Pain.
[24] M. Perloff,et al. Anorgasmia with gabapentin may be common in older patients. , 2011, The American journal of geriatric pharmacotherapy.
[25] R. Baron,et al. Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia , 2011, BMC neurology.
[26] G. Zaccara,et al. The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trials , 2011, Epilepsia.
[27] P. Wiffen,et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. , 2011, The Cochrane database of systematic reviews.
[28] P. Wiffen,et al. Lamotrigine for acute and chronic pain. , 2011, The Cochrane database of systematic reviews.
[29] P. Wiffen,et al. Carbamazepine for acute and chronic pain in adults. , 2011, The Cochrane database of systematic reviews.
[30] A. Rice,et al. Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials , 2010, PloS one.
[31] G. Zlateva,et al. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies , 2010, BMC family practice.
[32] F. Barrantes,et al. The Anticonvulsive Drug Lamotrigine Blocks Neuronal α4β2 Nicotinic Acetylcholine Receptors , 2010, Journal of Pharmacology and Experimental Therapeutics.
[33] C. Eccleston,et al. “Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews , 2010, PAIN.
[34] T. Nurmikko,et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.
[35] Douglas G Altman,et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study , 2010, BMJ : British Medical Journal.
[36] S. Straube,et al. Pregabalin in fibromyalgia - responder analysis from individual patient data , 2010, BMC musculoskeletal disorders.
[37] S. Straube,et al. Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain , 2010, PAIN®.
[38] M. Rowbotham,et al. Clinical effectiveness: An approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences , 2010, PAIN®.
[39] F. Wolfe,et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.
[40] Jose Alvir,et al. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? , 2010, PAIN®.
[41] T. Alsaadi,et al. Guidelines for the Pharmacological Treatment of Peripheral Neuropathic Pain: Expert Panel Recommendations for the Middle East Region , 2010, The Journal of international medical research.
[42] A. Jadad,et al. Anticonvulsant drugs for acute and chronic pain. , 2010, The Cochrane database of systematic reviews.
[43] A. Jadad,et al. Anticonvulsant drugs for acute and chronic pain. , 2010, The Cochrane database of systematic reviews.
[44] Yuan-Tsong Chen,et al. Genetic predisposition of life-threatening antiepileptic-induced skin reactions , 2010, Expert opinion on drug safety.
[45] J. Dieleman,et al. Incidence of facial pain in the general population , 2009, PAIN®.
[46] Stephen J. Smith,et al. Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis , 2009, Cell.
[47] R. Hughes,et al. Duloxetine for treating painful neuropathy or chronic pain. , 2009, The Cochrane database of systematic reviews.
[48] R. Dworkin,et al. Treatment of neuropathic pain: an overview of recent guidelines. , 2009, The American journal of medicine.
[49] P. Wiffen,et al. Pregabalin for acute and chronic pain in adults. , 2009, The Cochrane database of systematic reviews.
[50] A. Beydoun,et al. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures , 2009, Expert review of neurotherapeutics.
[51] S. Straube,et al. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. , 2008, British journal of clinical pharmacology.
[52] R. Moore,et al. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials , 2008, BMC neurology.
[53] B. Laurent,et al. Prevalence of chronic pain with neuropathic characteristics in the general population , 2008, PAIN.
[54] F. Petzke,et al. Medikamentöse Therapie des Fibromyalgiesyndroms , 2008, Der Schmerz.
[55] D. Carroll,et al. Primary care incidence and treatment of four neuropathic pain conditions: A descriptive study, 2002–2005 , 2008, BMC family practice.
[56] J. Dostrovsky,et al. Neuropathic pain , 2008, Neurology.
[57] R. Moore,et al. Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain , 2008, PAIN.
[58] G. Lees,et al. The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels , 2008, Molecular Pharmacology.
[59] D. Bouhassira,et al. Brain imaging of neuropathic pain , 2007, NeuroImage.
[60] J. Farrar,et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.
[61] T. Dorner,et al. Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey , 2007, Acta anaesthesiologica Scandinavica.
[62] P. Tugwell,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.
[63] Blair H. Smith,et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. , 2006, The journal of pain : official journal of the American Pain Society.
[64] H. J. McQuay,et al. Algorithm for neuropathic pain treatment: An evidence based proposal , 2005, Pain.
[65] D G Altman,et al. Indirect comparisons of competing interventions. , 2005, Health technology assessment.
[66] M. Smaldone,et al. Epilepsy and erectile dysfunction: a review , 2004, Seizure.
[67] Douglas G Altman,et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.
[68] S. Libretto,et al. The Rationale and Use of Topiramate for Treating Neuropathic Pain , 2003, The Clinical journal of pain.
[69] E A Harvey,et al. The teratogenicity of anticonvulsant drugs. , 2001, The New England journal of medicine.
[70] G. McCleane. Lamotrigine in the management of neuropathic pain: a review of the literature. , 2000, The Clinical journal of pain.
[71] P. Lee,et al. Publication bias in meta-analysis: its causes and consequences. , 2000, Journal of clinical epidemiology.
[72] C. Woolf,et al. Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.
[73] Sean C. Sweetman. Martindale: The Complete Drug Reference , 1999 .
[74] Dawn Carroll,et al. Anticonvulsant drugs for management of pain: a systematic review , 1995, BMJ.
[75] M. Devor,et al. Trigeminal neuralgia: The role of self-sustaining discharge in the trigeminal ganglion , 1994, Pain.
[76] Denise Kendrick,et al. Health care needs assessment , 1993 .
[77] P. Tugwell,et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.
[78] J. Aronson,et al. Oxford Textbook of Clinical Pharmacology and Drug Therapy , 1985 .
[79] A. Webb,et al. Torulopsis glabrata septicaemia treated with 5-fluorocytosine. , 1970, Lancet.
[80] S. Blom. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). , 1962, Lancet.
[81] J. Rowlingson,et al. Textbook of Pain , 2015 .
[82] A. Dickenson,et al. Anti-convulsants and anti-depressants. , 2007, Handbook of experimental pharmacology.
[83] J. Stinson,et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. , 2007, Pain research & management.
[84] McNally Jd,et al. The epidemiology of self-reported fibromyalgia in Canada. , 2006 .
[85] M. Tóth. The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate. , 2005, Medical hypotheses.
[86] F. Song,et al. In collaboration with the International Stroke Trial Collaborative Group. Indirect comparisons of competing interventions , 2005 .
[87] E. Bergstralh,et al. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. , 1991, Neuroepidemiology.
[88] Tw. Rall,et al. Drugs effective in the therapy of the epilepsies , 1985 .